Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Charles A. Adeniran"'
Autor:
Wen Zhang, Vitaliy M. Sviripa, Yanqi Xie, Tianxin Yu, Meghan G. Haney, Jessica S. Blackburn, Charles A. Adeniran, Chang-Guo Zhan, David S. Watt, Chunming Liu
Publikováno v:
iScience, Vol 23, Iss 12, Pp 101795- (2020)
Summary: Aberrant activation of Wnt signaling triggered by mutations in either Adenomatous Polyposis Coli (APC) or CTNNB1 (β-catenin) is a hallmark of colorectal cancers (CRC). As part of a program to develop epigenetic regulators for cancer therapy
Externí odkaz:
https://doaj.org/article/c10f7711030744a6997f7f1ff875703c
Autor:
Sarah Elizabeth B Davis, Yaxia Yuan, Ciai Lin, Chang-Guo Zhan, Charles A. Adeniran, Jun Zhu, Jiahui Xu
Publikováno v:
ACS Chem Neurosci
The increase of HIV infection in macrophages results in HIV proteins being released, like HIV Tat which impairs the function of monoamine transporters. HIV-infected patients have displayed increased synaptic levels of dopamine (DA) due to reduced bin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89b503e7c4edf500e97e088870ebede2
https://doi.org/10.1021/acschemneuro.0c00792
https://doi.org/10.1021/acschemneuro.0c00792
Autor:
Jun Zhu, Pamela M. Quizon, Yingying Wang, Charles A. Adeniran, Matthew J. Strauss, Ana C. Jiménez-Torres, Palak Patel, Thomas J. Cirino, Shainnel O. Eans, Haylee R. Hammond, Laure S. Deliscar, Priscilla O'Hara, Surendra K. Saini, Edward Ofori, Rakesh H. Vekariya, Sixue Zhang, Omar Moukha-Chafiq, Theresa H. Nguyen, Subramaniam Ananthan, Corinne E. Augelli-Szafran, Chang-Guo Zhan, Jay P. McLaughlin
Publikováno v:
Neuropharmacology. 220:109239
Cocaine abuse increases the incidence of HIV-1-associated neurocognitive disorders. We have demonstrated that HIV-1 transactivator of transcription (Tat) allosterically modulates dopamine (DA) reuptake through the human DA transporter (hDAT), potenti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71682d17ddd28faabd3009ffcb72ad40
https://doi.org/10.1016/j.neuropharm.2022.109239
https://doi.org/10.1016/j.neuropharm.2022.109239
Autor:
Tianxin Yu, Vitaliy M. Sviripa, Meghan G. Haney, Wen Zhang, David S. Watt, Chunming Liu, Yanqi Xie, Chang-Guo Zhan, Charles A. Adeniran, Jessica S. Blackburn
Publikováno v:
iScience, Vol 23, Iss 12, Pp 101795-(2020)
iScience
iScience
Summary Aberrant activation of Wnt signaling triggered by mutations in either Adenomatous Polyposis Coli (APC) or CTNNB1 (β-catenin) is a hallmark of colorectal cancers (CRC). As part of a program to develop epigenetic regulators for cancer therapy,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::321e8ad758fad2e84ebca619944b6a49
https://doi.org/10.1016/j.isci.2020.101795
https://doi.org/10.1016/j.isci.2020.101795